This site uses technical cookies and profiling third party cookies to offer a better user experience; third party cookies require your consent. By continuing to browse the site, clicking or tapping the screen, scrolling the web page or closing this banner, you are agreeing to our use of cookies. For further information or opt out options.
IMA is loading

Main Financial Data 2018

Main Data: 31/12 Year 2018
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 1,500.37
– industrial gross profit 572.04
– total operating cost 361.98
– operating profit 210.06
– net financial expense o.54
– profit attributable to equity holders of the parent 104.03

 

Consolidated balance sheet Millions/Euro
– working capital 99.08
– non-current assets 623.66
– provision for severance indemnities and other provisions -117.23
– net debt -184.58
– equity pertaining to the group and minority interests 420.93

 

Other information Millions/Euro
– depreciation and amortization and impairement 44.08
– R & D costs 55.31

 

  Euro
Dividend per share 1.70

 

  No.
Employees 5,456

 

  Euro
Share capital 20,415,200

 

Net Sales By Sector: Year 2018
  Millions/Euro  
tea, food & other 686.17 45.7%
pharmaceutical 631.27 42.1%
tobacco packaging 182.93 12.2%
Total 1,500.37 100.0%

 

Net Sales by Country: Year 2018
  Millions/Euro  
E.U. (excluding Italy) 450.01 30.0%
Other European countries 114.97 7.7%
North America 241.13 16.1%
Asia & Middle East 375.66 25.0%
Other countries 150.95 10.0%
Total exports 1,332.72 88.8%
Italy 167.65 11.2%
Total 1,500.37 100.0%

 

Main Data: 30/06 Year 2018
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenue 730.1
– industrial gross profit  264.5
– total operating cost 195.3
– operating profit 69.2
– net financial income 5.8
– profit attributable to equity holders of the parent 43.9

 

Consolidated balance sheet Millions/Euro
– working capital 84.3
– non-current assets 643.3
– provision for severance indemnities and other provisions -140.2
– net debt -230.5
– equity pertaining to the group and minority interests 356.9

 

Other information Millions/Euro
– depreciation and amortization 22.7
– R & D costs 29.0

 

  No.
Employees 5,729

 

  Euro
Share capital 20,415,200